Compare drug alternatives

Farxiga® Alternatives

Farxiga®(Dapagliflozin)
Soliqua®(Insulin Glargine And Lixisenatide)
Prescription Only
Farxiga (dapagliflozin) is an oral medication prescribed for individuals with diabetes, heart disease, or kidney disease to enhance their health outcomes. Here's how Farxiga is...
Prescription Only
Soliqua 100/33 is a combination medication featuring insulin glargine and lixisenatide. Insulin glargine offers prolonged blood glucose reduction, while lixisenatide enhances...
Dosage & AdministrationDosage & Administration comparison data
Administration
Oral . Learn more.
Dosing
Recommended starting dose is 5 mg orally once daily. Dose can be increased to 10 mg orally once daily for additional glycemic control. . Learn more.
Latin Shorthand
Starting Dose: 5mg PO qd. Can be increased to 10mg PO qd for additional glycemic control.. Learn more.
Financial AssistanceFinancial Assistance comparison data
Out-Of-Pocket Costs With Copay Card
Annual Cap
$175 per month. Learn more.
Assistance Expiration
Generics
No lower-cost generic available
No lower-cost generic available
Physician AdvisoryPhysician Advisory comparison data
Adverse Reactions
Most common adverse reactions (5% or greater incidence) were female genital mycotic infections, nasopharyngitis, and urinary tract infections. . Learn more.
The most common adverse reactions, reported in ≥5% of patients treated with SOLIQUA 100/33 include hypoglycemia, nausea, nasopharyngitis, diarrhea, upper respiratory tract infection, and headache.. Learn more.
Mechanism of Actions (MoA)
SGLT2 Inhibitors. Learn more.
Special Populations